Patents Assigned to Biothea Pharma, Inc.
  • CRYSTALLINE EPINEPHRINE MALONATE SALT
    Publication number: 20250051262
    Abstract: Described herein are epinephrine salts, specifically the epinephrine malonate salt; the epinephrine malonate salt in crystalline form; a pharmaceutical composition comprising epinephrine malonate; a sublingual or buccal pharmaceutical composition comprising epinephrine malonate in crystalline form; and a method for treating a patient comprising administering a pharmaceutical composition of epinephrine malonate in crystalline form.
    Type: Application
    Filed: October 29, 2024
    Publication date: February 13, 2025
    Applicant: Biothea Pharma, Inc.
    Inventors: Jean-Pierre Sommadossi, Adel Moussa
  • Crystalline epinephrine malonate salt
    Patent number: 12134588
    Abstract: Described herein are epinephrine salts, specifically the epinephrine malonate salt; the epinephrine malonate salt in crystalline form; a pharmaceutical composition comprising epinephrine malonate; a sublingual or buccal pharmaceutical composition comprising epinephrine malonate in crystalline form; and a method for treating a patient comprising administering a pharmaceutical composition of epinephrine malonate in crystalline form.
    Type: Grant
    Filed: November 18, 2022
    Date of Patent: November 5, 2024
    Assignee: Biothea Pharma, Inc.
    Inventors: Jean-Pierre Sommadossi, Adel Moussa
  • CRYSTALLINE EPINEPHRINE MALONATE SALT
    Publication number: 20230086578
    Abstract: Described herein are epinephrine salts, specifically the epinephrine malonate salt; the epinephrine malonate salt in crystalline form; a pharmaceutical composition comprising epinephrine malonate; a sublingual or buccal pharmaceutical composition comprising epinephrine malonate in crystalline form; and a method for treating a patient comprising administering a pharmaceutical composition of epinephrine malonate in crystalline form.
    Type: Application
    Filed: November 18, 2022
    Publication date: March 23, 2023
    Applicant: Biothea Pharma, Inc.
    Inventors: Jean-Pierre Sommadossi, Adel Moussa
  • Crystalline epinephrine malonate salt
    Patent number: 11505521
    Abstract: Described herein are epinephrine salts, specifically the epinephrine malonate salt; the epinephrine malonate salt in crystalline form; a pharmaceutical composition comprising epinephrine malonate; a sublingual or buccal pharmaceutical composition comprising epinephrine malonate in crystalline form; and a method for treating a patient comprising administering a pharmaceutical composition of epinephrine malonate in crystalline form.
    Type: Grant
    Filed: March 29, 2021
    Date of Patent: November 22, 2022
    Assignee: Biothea Pharma, Inc.
    Inventors: Jean-Pierre Sommadossi, Adel Moussa
  • CRYSTALLINE EPINEPHRINE MALONATE SALT
    Publication number: 20210214301
    Abstract: Described herein are epinephrine salts, specifically the epinephrine malonate salt; the epinephrine malonate salt in crystalline form; a pharmaceutical composition comprising epinephrine malonate; a sublingual or buccal pharmaceutical composition comprising epinephrine malonate in crystalline form; and a method for treating a patient comprising administering a pharmaceutical composition of epinephrine malonate in crystalline form.
    Type: Application
    Filed: March 29, 2021
    Publication date: July 15, 2021
    Applicant: Biothea Pharma, Inc.
    Inventors: Jean-Pierre Sommadossi, Adel Moussa
  • Crystalline epinephrine malonate salt
    Patent number: 10995059
    Abstract: Described herein are epinephrine salts, specifically the epinephrine malonate salt; the epinephrine malonate salt in crystalline form; a pharmaceutical composition comprising epinephrine malonate; a sublingual or buccal pharmaceutical composition comprising epinephrine malonate in crystalline form; and a method for treating a patient comprising administering a pharmaceutical composition of epinephrine malonate in crystalline form.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: May 4, 2021
    Assignee: Biothea Pharma, Inc.
    Inventors: Jean-Pierre Sommadossi, Adel Moussa
  • CRYSTALLINE EPINEPHRINE MALONATE SALT
    Publication number: 20200031758
    Abstract: Described herein are epinephrine salts, specifically the epinephrine malonate salt; the epinephrine malonate salt in crystalline form; a pharmaceutical composition comprising epinephrine malonate; a sublingual or buccal pharmaceutical composition comprising epinephrine malonate in crystalline form; and a method for treating a patient comprising administering a pharmaceutical composition of epinephrine malonate in crystalline form.
    Type: Application
    Filed: July 30, 2019
    Publication date: January 30, 2020
    Applicant: Biothea Pharma, Inc.
    Inventors: Jean-Pierre Sommadossi, Adel Moussa